Resting Heart Rate and Incident Heart Failure and Cardiovascular Mortality in Older Adults: Role of Inflammation and Endothelial Dysfunction: The PROSPER Study
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Aims: Resting heart rate is a promising modifiable cardiovascular risk marker in older adults, but the mechanisms linking heart rate to cardiovascular disease are not fully understood. We aimed to assess the association between resting heart rate and incident heart failure (HF) and cardiovascular mortality, and to examine whether these associations might be attributable to systemic inflammation and endothelial dysfunction. Methods and results: We studied 4084 older adults aged 70–82 years with known cardiovascular risk factors or previous cardiovascular disease, without pre-existing HF or beta-blockers in the PROSPER study. Over a 3.2-year follow-up period, we examined incident HF hospitalization and cardiovascular mortality according to resting heart rate, along with C-reactive protein (CRP), interleukin-6 (IL-6), tissue plasminogen activator (tPA), and von Willebrand factor (vWf). Mean heart rate was 67 b.p.m. for men and 70 b.p.m. for women. CRP, IL-6, tPA, and vWf levels were all positively correlated with heart rate. After multivariate adjustment, heart rate was associated with HF hospitalization [hazard ratio (HR) 1.78 for highest vs. lowest distribution third, 95% confidence interval (CI) 1.21–2.63, P= 0.003] and cardiovascular mortality (HR 1.74, 95% CI 1.23–2.47, P= 0.002). Further adjustment for both IL-6 and vWf levels decreased HR to 1.60 (95% CI 1.08–2.38, P= 0.020) for HF and to 1.50 (95% CI 1.04–2.15, P= 0.028) for cardiovascular mortality. Conclusion: Increased heart rate is associated with increased systemic inflammation and endothelial dysfunction. These factors are likely to contribute to, but do not fully explain, the risk of HF and cardiovascular death associated with increased heart rate in older age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
Self-citationIvabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61198-1 · Cited by 2,563 · cited 1×
“Ivabradine is a new drug that specifically inhibits the sinus node without influencing blood pressure.(25,26) In the SHIFT trail, the benefit of reducing heart rate with ivabradine was the greatest with the highest heart rate levels,(25) and ivabradine is only licensed for heart failure patient with heart rate .”
BackgroundSelf-citationFox, K., Ford, I., Steg, P. G., Tendera, M., & Ferrari, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61170-8 · Cited by 1,099 · cited 1×
“Ivabradine is a new drug that specifically inhibits the sinus node without influencing blood pressure.(25,26) In the SHIFT trail, the benefit of reducing heart rate with ivabradine was the greatest with the highest heart rate levels,(25) and ivabradine is only licensed for heart failure patient with heart rate .”
BackgroundSelf-citationEndothelial Function: A Critical Determinant in Atherosclerosis?
Landmesser, U., Hornig, B., & Drexler, H. (2004) · Circulation · doi:10.1161/01.cir.0000129501.88485.1f · Cited by 851
Diaz, A., Bourassa, M. G., Guertin, M.-C., & Tardif, J.-C. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi190 · Cited by 790
de Ruijter, W., Westendorp, R. G. J., Assendelft, W. J. J., den Elzen, W. P. J., de Craen, A. J. M., le Cessie, S., & Gussekloo, J. (2009) · BMJ · doi:10.1136/bmj.a3083 · Cited by 339
Self-citationDecreased heart rate variability is associated with higher levels of inflammation in middle-aged men
Lampert, R., Bremner, J. D., Su, S., Miller, A., Lee, F., Cheema, F., Goldberg, J., & Vaccarino, V. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.07.009 · Cited by 240 · cited 2×
“Inflammatory markers such as CRP or IL-6 levels have been related to the autonomic nervous system in previous cross-sectional studies, suggesting that inflammation might modify heart rate by impacting on the autonomic nervous system.(8,9) Our results confirm the close relationship between resting heart rate and system…”
BackgroundResultNanchen, D., Gussekloo, J., Westendorp, R. G. J., Stott, D. J., Jukema, J. W., Trompet, S., Ford, I., Welsh, P., Sattar, N., Macfarlane, P. W., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1978 · Cited by 211
Self-citation
Cited by
Aune, D., Giovannucci, E., Boffetta, P., Fadnes, L. T., Keum, N., Norat, T., Greenwood, D. C., Riboli, E., Vatten, L. J., & Tonstad, S. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyw319 · Cited by 2,419
Aune, D., Sen, A., ó'Hartaigh, B., Janszky, I., Romundstad, P. R., Tonstad, S., & Vatten, L. J. (2017) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.04.004 · Cited by 284
Resting Heart Rate: Risk Indicator and Emerging Risk Factor in Cardiovascular Disease
Böhm, M., Reil, J.-C., Deedwania, P., Kim, J. B., & Borer, J. S. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.09.016 · Cited by 236
Heart rate as a predictor of cardiovascular risk
Tadic, M., Cuspidi, C., & Grassi, G. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12892 · Cited by 97
Ó Hartaigh, B., Gill, T. M., Shah, I., Hughes, A. D., Deanfield, J. E., Kuh, D., & Hardy, R. (2014) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2014-203940 · Cited by 40
Metadata
- Authors
- Nanchen, D., Stott, D. J., Gussekloo, J., Mooijaart, S. P., Westendorp, R. G. J., Jukema, J. W., Macfarlane, P. W., Cornuz, J., Rodondi, N., Buckley, B. M., Ford, I., Sattar, N., & de Craen, A. J. M.
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-05-01
- Volume
- 15
- Issue
- 5
- Pages
- 581-588
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W1965296552
- Cited by
- 75
- References
- 8
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Resting Heart Rate and Incident Heart Failure and Cardiovascular Mortality in Older Adults: Role of Inflammation and Endothelial Dysfunction: The PROSPER Study. https://app.cochat.ai/papers/10.1093/eurjhf/hfs195
- The paper
- Nanchen, D., Stott, D. J., Gussekloo, J., Mooijaart, S. P., Westendorp, R. G. J., Jukema, J. W., Macfarlane, P. W., Cornuz, J., Rodondi, N., Buckley, B. M., Ford, I., Sattar, N., & de Craen, A. J. M. (2013). Resting Heart Rate and Incident Heart Failure and Cardiovascular Mortality in Older Adults: Role of Inflammation and Endothelial Dysfunction: The PROSPER Study. European Journal of Heart Failure. https://doi.org/10.1093/eurjhf/hfs195
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.